DK0902783T3 - Hydrolysefremmende, hydrofobe taxanderivater - Google Patents
Hydrolysefremmende, hydrofobe taxanderivaterInfo
- Publication number
- DK0902783T3 DK0902783T3 DK96930847T DK96930847T DK0902783T3 DK 0902783 T3 DK0902783 T3 DK 0902783T3 DK 96930847 T DK96930847 T DK 96930847T DK 96930847 T DK96930847 T DK 96930847T DK 0902783 T3 DK0902783 T3 DK 0902783T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrolysis
- taxane
- hydrocarbon
- promoting
- taxane derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US357595P | 1995-09-12 | 1995-09-12 | |
PCT/US1996/014631 WO1997010234A1 (en) | 1995-09-12 | 1996-09-12 | Hydrolysis-promoting taxane hydrophobic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0902783T3 true DK0902783T3 (da) | 2002-07-22 |
Family
ID=21706522
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96930847T DK0902783T3 (da) | 1995-09-12 | 1996-09-12 | Hydrolysefremmende, hydrofobe taxanderivater |
DK02008590T DK1229030T3 (da) | 1995-09-12 | 1996-09-12 | Hydrolysefremmende, hydrofobe taxanderivater |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02008590T DK1229030T3 (da) | 1995-09-12 | 1996-09-12 | Hydrolysefremmende, hydrofobe taxanderivater |
Country Status (22)
Country | Link |
---|---|
US (1) | US5703117A (hu) |
EP (1) | EP0902783B1 (hu) |
JP (1) | JP4192208B2 (hu) |
KR (1) | KR100401220B1 (hu) |
CN (1) | CN1100770C (hu) |
AT (2) | ATE309235T1 (hu) |
CA (1) | CA2231750C (hu) |
CZ (1) | CZ288562B6 (hu) |
DE (2) | DE69620802T2 (hu) |
DK (2) | DK0902783T3 (hu) |
ES (2) | ES2179208T3 (hu) |
HK (1) | HK1016169A1 (hu) |
HU (1) | HU226325B1 (hu) |
IL (1) | IL123595A (hu) |
MX (1) | MX9801871A (hu) |
NO (1) | NO319521B1 (hu) |
NZ (1) | NZ318300A (hu) |
PL (1) | PL187738B1 (hu) |
PT (1) | PT902783E (hu) |
SK (1) | SK283199B6 (hu) |
TR (1) | TR199800443T1 (hu) |
WO (1) | WO1997010234A1 (hu) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107332A (en) * | 1995-09-12 | 2000-08-22 | The Liposome Company, Inc. | Hydrolysis-promoting hydrophobic taxane derivatives |
US6667053B1 (en) * | 1996-02-16 | 2003-12-23 | Elan Pharmaceuticals, Inc. | D and L etherlipid stereoisomers and liposomes |
US5912264A (en) * | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
PT1964557E (pt) | 1997-11-10 | 2013-02-20 | Sloan Kettering Inst Cancer | Processo para a produção de formulações de trióxido de arsénio |
BR9911031A (pt) * | 1998-05-20 | 2002-01-29 | Liposome Co Inc | Novas formulações em partìculas |
US7314637B1 (en) | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6146659A (en) * | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
DE60004630T2 (de) * | 1999-01-12 | 2004-06-17 | Quanam Medical Corp., Santa Clara | Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
CA2410632A1 (en) | 2000-06-22 | 2001-12-27 | David S. Garvey | Nitrosated and nitrosylated taxanes, compositions and methods of use |
US6607689B1 (en) * | 2000-08-29 | 2003-08-19 | Micron Technology, Inc. | Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length |
EP1304103B1 (en) * | 2001-10-22 | 2008-12-31 | Viroblock SA | New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications |
EP1461056A4 (en) * | 2001-11-26 | 2006-01-25 | Supergen Inc | PROCESS FOR THE PREPARATION AND USE OF POLYOXYETHYLATED CICRIC OIL IN PHARMACEUTICAL COMPOSITIONS |
AU2003249882B2 (en) * | 2002-06-26 | 2008-09-18 | Medigene Ag | Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
WO2004069224A2 (en) | 2003-02-03 | 2004-08-19 | Neopharm, Inc. | Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
JP5139814B2 (ja) * | 2005-02-18 | 2013-02-06 | アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー | 医療装置に結合した改善された疎水性を有した薬剤 |
WO2006110862A2 (en) * | 2005-04-12 | 2006-10-19 | Wisconsin Alumni Research Foundation | Micelle composition of polymer and passenger drug |
JP2011517683A (ja) * | 2008-04-10 | 2011-06-16 | アブラクシス バイオサイエンス, エルエルシー | 疎水性タキサン誘導体の組成物およびその使用 |
AU2009234127B2 (en) * | 2008-04-10 | 2015-04-30 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
WO2011038278A2 (en) | 2009-09-25 | 2011-03-31 | Wisconsin Alumni Research Foundation | Micelle encapsulation of therapeutic agents |
CN105503844A (zh) * | 2015-12-11 | 2016-04-20 | 上海大学 | C-13和c-7位结构改造的紫杉醇类化合物及其制备方法 |
CN111004195B (zh) * | 2019-12-03 | 2022-01-28 | 沈阳药科大学 | 卡巴他赛弱碱性衍生物及其制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5278324A (en) * | 1990-08-28 | 1994-01-11 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
US5059699A (en) * | 1990-08-28 | 1991-10-22 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
EP0626953A4 (en) * | 1992-12-23 | 1995-05-03 | Bristol Myers Squibb Co | NEW SIDE CHAINS WEARING TAXANS AND THEIR INTERMEDIATE PRODUCTS. |
IL108316A (en) * | 1993-01-15 | 2006-10-31 | Univ Florida State | History of C-10 Texan and pharmaceuticals containing them |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
-
1996
- 1996-09-12 JP JP51210297A patent/JP4192208B2/ja not_active Expired - Fee Related
- 1996-09-12 MX MX9801871A patent/MX9801871A/es not_active IP Right Cessation
- 1996-09-12 TR TR1998/00443T patent/TR199800443T1/xx unknown
- 1996-09-12 NZ NZ318300A patent/NZ318300A/xx unknown
- 1996-09-12 WO PCT/US1996/014631 patent/WO1997010234A1/en active IP Right Grant
- 1996-09-12 CA CA002231750A patent/CA2231750C/en not_active Expired - Fee Related
- 1996-09-12 DK DK96930847T patent/DK0902783T3/da active
- 1996-09-12 PT PT96930847T patent/PT902783E/pt unknown
- 1996-09-12 EP EP96930847A patent/EP0902783B1/en not_active Expired - Lifetime
- 1996-09-12 HU HU9901433A patent/HU226325B1/hu unknown
- 1996-09-12 US US08/712,684 patent/US5703117A/en not_active Expired - Fee Related
- 1996-09-12 DE DE69620802T patent/DE69620802T2/de not_active Expired - Fee Related
- 1996-09-12 PL PL96325477A patent/PL187738B1/pl not_active IP Right Cessation
- 1996-09-12 IL IL12359596A patent/IL123595A/xx not_active IP Right Cessation
- 1996-09-12 AT AT02008590T patent/ATE309235T1/de not_active IP Right Cessation
- 1996-09-12 ES ES96930847T patent/ES2179208T3/es not_active Expired - Lifetime
- 1996-09-12 DK DK02008590T patent/DK1229030T3/da active
- 1996-09-12 AT AT96930847T patent/ATE216377T1/de not_active IP Right Cessation
- 1996-09-12 CN CN96198237A patent/CN1100770C/zh not_active Expired - Fee Related
- 1996-09-12 DE DE69635428T patent/DE69635428T2/de not_active Expired - Fee Related
- 1996-09-12 CZ CZ1998711A patent/CZ288562B6/cs not_active IP Right Cessation
- 1996-09-12 KR KR10-1998-0701653A patent/KR100401220B1/ko not_active IP Right Cessation
- 1996-09-12 SK SK334-98A patent/SK283199B6/sk unknown
- 1996-09-12 ES ES02008590T patent/ES2252347T3/es not_active Expired - Lifetime
-
1998
- 1998-03-11 NO NO19981071A patent/NO319521B1/no unknown
-
1999
- 1999-03-18 HK HK99101119A patent/HK1016169A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1229030T3 (da) | Hydrolysefremmende, hydrofobe taxanderivater | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
PT802911E (pt) | Derivados de taxano hidrofobos | |
CA2301057A1 (en) | A method of administering liposomal encapsulated taxane | |
DE69226197D1 (de) | Hämoglobine als arzneimittelabgabesystem | |
TR200102603T2 (tr) | Antitümör aktiviteye sahip olan kamptotesin türevleri | |
PT977564E (pt) | Forscolina para promocao da massa corporal magra | |
NL970006I2 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
ATE238733T1 (de) | Inhalierbares kontrastmittel | |
ATE324119T1 (de) | Verwendung von saccharid-konjugaten | |
CY1109695T1 (el) | Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο | |
ATE262515T1 (de) | Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie | |
SE8404283L (sv) | Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar | |
ATE141796T1 (de) | 2',5'-oligoadenylat-derivate zur verwendung als heilmittel | |
EP1229030A3 (en) | Hydrolysis-promoting taxane hydrophobic derivates | |
TR199901395T2 (xx) | Yeni karboksi ikameli siklik karboksamid t�revleri. | |
PT1058544E (pt) | Inibicao da actividade do tnf | |
ES8605989A1 (es) | Un metodo de preparar un complejo de fibronectina, dextrano y farmaco | |
RU94018405A (ru) | Устройство для воздействия магнитным полем | |
IT208536Z2 (it) | Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili. |